Eurocine Vaccines’ Director of Preclinical Development invited to lecture at UCL School of Pharmacy
Eurocine Vaccines (“Eurocine” or the “Company”) announces today that the Company’s Director of Preclinical Development, Dr. Karl Ljungberg, has lectured on DNA and RNA vaccines at one of the top ranked pharmacy schools in the UK. On February 16, Dr. Karl Ljungberg, the Company’s Director of Preclinical Development, was invited by Dr. Martinez Bravo to lecture at University College London, UCL School of Pharmacy, one of the UK’s top-ranked pharmacy schools. As part of a course module in “Applications of Immunology: Immunotherapy, vaccines and diagnostic techniques", Dr. Karl